As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
In an era defined by longer lives, rapid technological change and capital abundance, instinct alone is no longer enough. Here’s why evidence-based leadership is the true engine of sustainable innovation.
Lasting reinvention comes from deliberate, incremental moves rather than big, bold leaps. Here’s how building a portable reputation, clarity and optionality creates more resilient, future-proof careers.
When you’re building at breakneck speed, hiring a trusted team is crucial for an early-stage startup. Bland CEO and co-founder Isaiah Granet has tactical advice on how the company managed to find hidden talent in unlikely places.
Here’s what we know, and what you need to know, about Coruna and DarkSword, two advanced iPhone hacking tools discovered by security researchers. DarkSword has now leaked online.